Dr. Vijaya Raj Bhatt, MD

Dr. Bhatt practices at Nebraska Medical Center in Omaha, Nebraska, part of University of Nebraska System.

Dr. Bhatt's NPI, 1760612113, was assigned on July 20, 2009. Dr. Bhatt holds Nebraska license 28121.

Dr. Bhatt's primary practice is Nebraska Medical Center, at 988102 Nebrasks Medical Center, Omaha, NE 68198 in Douglas County. The practice phone is (402) 559-4000. Dr. Bhatt also practices at Nebraska Medical Center, 987400 Nebraska Medical Ctr, Omaha, NE 68198.

Dr. Bhatt's primary practice is Nebraska Medical Center in Omaha, Nebraska, part of University of Nebraska System. Dr. Bhatt is also affiliated with Bryan Medical Center. The medical group on file is UNMC Physicians. Dmand AI also links Dr. Bhatt to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bhatt practices, 3 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Bhatt's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Bhatt is licensed in Nebraska.

CMS data shows 415 Medicare services from Dr. Bhatt across 7 procedure codes in 2024, for 120 Medicare patients. Medicare paid $36,338 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 120 Medicare patients who saw Dr. Bhatt in 2024. The largest group is 65 to 74, with 76 patients. 68% of them have high blood pressure, and 60% have high cholesterol. 11% are also on Medicaid. Their average risk score is 3.19, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bhatt's median patient age at 70, with 34% women.

In 2024, Dr. Bhatt wrote 852 Medicare Part D claims for 67 patients. 70% of them were for generic drugs. CMS names the drug for 533 of them, across 18 drugs with 11 or more claims each, at $2,167,472 in total drug cost. In 2023, CMS named 675 claims across 27 drugs.

Dr. Bhatt accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bhatt as offering telehealth.

Dmand AI links 231 papers to Dr. Bhatt, published from 2010 to 2025. 2021 was the busiest year, with 16. The most frequent topics are Hematopoietic Stem Cell Transplantation, Leukemia, Myeloid, Acute and Transplantation, Homologous. Dr. Bhatt has published most often in Future Oncol. Dr. Bhatt's most frequent co-authors are Prajwal Dhakal, MBBS, Smith Giri and Ranjan Pathak, MD.

Dmand AI links Dr. Bhatt to 8 clinical trials, 5 of them phase 2 studies. 1 is still active or recruiting. Conditions studied include Leukemia, Myeloid, Acute, Leukemia, Myeloid and Bronchiolitis Obliterans Syndrome. University of Nebraska sponsors the most, 2.

CMS Open Payments shows 111 general payments to Dr. Bhatt from 19 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 70% of the total. Incyte Corporation paid the most, $11,181.